調查批次 : RH2025-01 | 檢體寄出日期:2025 年 02 月 17 日 | 報告回收截止日期:2025 月 02 月 24 日 |
寄出份數 : 25 份 | 回收份數(比率) : 25 (100%) |
1.至本次歷年品管檢體「調查批次」與「實驗室間 CV」分佈圖 | 4.本次 G6PD 定量檢驗結果分佈圖 |
2.至本次歷年品管檢體「G6PD 活性值」與「實驗室間 CV」分佈圖 | 5.本次血色素 (Hb) 定量檢驗結果分佈圖 |
3.至本次各單位 z′ score, D% 及 SDI 分佈圖列表 | 6.其他報告 |
各單位G6PD及血色素(Hb)定量檢驗院際品管調查結果一覽表
檢驗單位 代碼 |
確診醫院 代碼 |
回報時效 (天) |
G6PD Reagent Code |
Sample 1 | Sample 2 | Sample 3 | Hb 1 | Hb 2 | Hb 3 | |||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
(U/g Hb) | D% | z′ score | SDI | (U/g Hb) | D% | z′ score | SDI | (U/g Hb) | D% | z′ score | SDI | (g/dL) | (g/dL) | (g/dL) | ||||||||||||||
RH01 | RH01 RH05 |
1 | 3 | 14.1 | -1.4% | -0.2 | -0.3 | 6.9 | 1.5% | 0.2 | 0.4 | 10.7 | 5.9% | 0.8 | 1.0 | 2.3 | 2.1 | 3.0 | ||||||||||
RH02 | RH02 | 7 | 4 | 15.5 | 8.4% | 1.2 | 2.0 | 7.1 | 4.4% | 0.6 | 0.7 | 10.4 | 3.0% | 0.4 | 0.6 | 2.5 | 2.3 | 3.1 | ||||||||||
RH04 | RH04 | 4 | 3 | 13.8 | -3.5% | -0.5 | -0.8 | 6.0 | -11.8% | -1.6 | -1.3 | 10.1 | 0.0% | 0.0 | 0.3 | 2.4 | 2.2 | 3.0 | ||||||||||
RH06 | RH06 | 7 | 3 | 13.8 | -3.5% | -0.5 | -0.8 | 6.3 | -7.4% | -1.0 | -0.7 | 10.1 | 0.0% | 0.0 | 0.3 | 2.4 | 2.2 | 3.0 | ||||||||||
RH07 | RH07 | 4 | 3 | 13.9 | -2.8% | -0.4 | -0.7 | 6.7 | -1.5% | -0.2 | 0.0 | 10.1 | 0.0% | 0.0 | 0.3 | 2.4 | 2.1 | 3.0 | ||||||||||
RH08 | RH08 | 7 | 3 | 14.8 | 3.5% | 0.5 | 0.8 | 6.8 | 0.0% | 0.0 | 0.2 | 10.4 | 3.0% | 0.4 | 0.6 | 2.3 | 2.2 | 3.0 | ||||||||||
RH09 | RH09 | 3 | 4 | 14.6 | 2.1% | 0.3 | 0.5 | 6.5 | -4.4% | -0.6 | -0.4 | 9.9 | -2.0% | -0.3 | 0.0 | 2.1 | 1.9 | 2.7 | ||||||||||
RH10 | RH10 | 7 | 4 | 14.8 | 3.5% | 0.5 | 0.8 | 7.4 | 8.8% | 1.2 | 1.3 | 9.0 | -10.9% | -1.5 | -1.2 | 2.1 | 1.9 | 2.8 | ||||||||||
RH12 | RH12 | 4 | 4 | 15.0 | 4.9% | 0.7 | 1.1 | 6.8 | 0.0% | 0.0 | 0.2 | 10.0 | -1.0% | -0.1 | 0.1 | 2.3 | 2.1 | 3.0 | ||||||||||
RH13 | RH13 | 1 | 4 | 14.1 | -1.4% | -0.2 | -0.3 | 6.5 | -4.4% | -0.6 | -0.4 | 9.7 | -4.0% | -0.6 | -0.3 | 2.4 | 2.1 | 3.1 | ||||||||||
RH14 | RH14 | 7 | 3 | 15.6 | 9.1% | 1.3 | 2.1 | 7.5 | 10.3% | 1.4 | 1.5 | 11.3 | 11.9% | 1.7 | 1.8 | 2.5 | 2.3 | 3.3 | ||||||||||
RH19 | RH19 | 3 | 4 | 13.5 | -5.6% | -0.8 | -1.3 | 6.2 | -8.8% | -1.2 | -0.9 | 9.7 | -4.0% | -0.6 | -0.3 | 2.2 | 2.2 | 3.1 | ||||||||||
A0189 | A0189 | 7 | 4 | 15.3 | 7.0% | 1.0 | 1.6 | 6.3 | -7.4% | -1.0 | -0.7 | 10.7 | 5.9% | 0.8 | 1.0 | 2.1 | 1.9 | 2.8 | ||||||||||
A0203 | RH18 CL020 |
3 | 3 | 14.3 | 0.0% | 0.0 | 0.0 | 6.5 | -4.4% | -0.6 | -0.4 | 10.7 | 5.9% | 0.8 | 1.0 | 2.5 | 2.2 | 3.0 | ||||||||||
G026 | G026 | 7 | 3 | 14.2 | -0.7% | -0.1 | -0.2 | 7.4 | 8.8% | 1.2 | 1.3 | 9.6 | -5.0% | -0.7 | -0.4 | 2.3 | 2.1 | 3.0 | ||||||||||
CL001 | CL001 | 3 | 4 | 14.1 | -1.4% | -0.2 | -0.3 | 7.1 | 4.4% | 0.6 | 0.7 | 8.2 | -18.8% | -2.6 | -2.2 | 2.3 | 2.1 | 3.0 | ||||||||||
CL002 | RH03 RH11 RH17 G031 B005 CL016 A0511 CL021 CL022 |
2 | 3 | 13.0 | -9.1% | -1.3 | -2.1 | 6.1 | -10.3% | -1.4 | -1.1 | 9.1 | -9.9% | -1.4 | -1.0 | 2.3 | 2.1 | 3.0 | ||||||||||
CL003 | RH16 | 4 | 4 | 13.8 | -3.5% | -0.5 | -0.8 | 6.2 | -8.8% | -1.2 | -0.9 | 8.8 | -12.9% | -1.8 | -1.4 | 2.4 | 2.2 | 3.1 | ||||||||||
CL004 | CL004 | 2 | 3 | 13.8 | -3.5% | -0.5 | -0.8 | 6.2 | -8.8% | -1.2 | -0.9 | 9.2 | -8.9% | -1.2 | -0.9 | 2.4 | 2.1 | 3.0 | ||||||||||
CL014 | CL014 | 7 | 3 | 14.3 | 0.0% | 0.0 | 0.0 | 7.3 | 7.4% | 1.0 | 1.1 | 10.3 | 2.0% | 0.3 | 0.5 | 2.3 | 2.1 | 2.8 | ||||||||||
CL015B | CL015B | 7 | 3 | 14.3 | 0.0% | 0.0 | 0.0 | 6.3 | -7.4% | -1.0 | -0.7 | 10.1 | 0.0% | 0.0 | 0.3 | 2.4 | 2.2 | 3.1 | ||||||||||
CL017 | CL017 | 3 | 4 | 14.3 | 0.0% | 0.0 | 0.0 | 6.8 | 0.0% | 0.0 | 0.2 | 7.1 | -29.7% | -4.1 | -3.6 | 2.2 | 2.0 | 2.9 | ||||||||||
CL018 | CL018 | 4 | 3 | 14.5 | 1.4% | 0.2 | 0.3 | 7.9 | 16.2% | 2.2 | 2.2 | 10.9 | 7.9% | 1.1 | 1.3 | 2.4 | 2.1 | 2.9 | ||||||||||
CL019 | CL019 | 3 | 3 | 14.9 | 4.2% | 0.6 | 1.0 | 6.8 | 0.0% | 0.0 | 0.2 | 10.2 | 1.0% | 0.1 | 0.4 | 2.2 | 2.0 | 2.9 | ||||||||||
CL023 | CL023 | 7 | 3 | 14.5 | 1.4% | 0.2 | 0.3 | 7.2 | 5.9% | 0.8 | 0.9 | 10.1 | 0.0% | 0.0 | 0.3 | 2.3 | 2.0 | 2.9 | ||||||||||
Total participating laboratories = 25 | ||||||||||||||||||||||||||||
Xa (Median) | - | 4 | - | 14.3 | 6.8 | 10.1 | 2.3 | 2.1 | 3.0 | |||||||||||||||||||
uXa | - | - | - | 0.134 | 0.119 | 0.169 | - | - | - | |||||||||||||||||||
σp | - | - | - | 1.001 | 0.476 | 0.707 | - | - | - | |||||||||||||||||||
Range | - | 1-7 | - | 13.0-15.6 | 6.0-7.9 | 7.1-11.3 | 2.1-2.5 | 1.9-2.3 | 2.7-3.3 | |||||||||||||||||||
n | - | - | - | 25 | 25 | 25 | 25 | 25 | 25 | |||||||||||||||||||
Mean | - | - | - | 14.3 | 6.7 | 9.9 | 2.3 | 2.1 | 3.0 | |||||||||||||||||||
SD | - | - | - | 0.61 | 0.54 | 0.77 | 0.13 | 0.11 | 0.12 | |||||||||||||||||||
CV | - | - | - | 4.3% | 8.1% | 7.8% | 5.7% | 5.2% | 4.0% | |||||||||||||||||||
|
G6PD Reagent Code |
Lab |
|
Innovation | 3 | A0203, CL002, CL004, CL014, CL015B, CL018, CL019, CL023, G026, RH01, RH04, RH06, RH07, RH08, RH14 |
Lanner | 4 | A0189, CL001, CL003, CL017, RH02, RH09, RH10, RH12, RH13, RH19 |
若有任何疑問,歡迎來電(函)聯繫或指教
地 址:10699
臺北信維郵局第 624 信箱 電 話:(02)2703-6080
e-mail:
傳 真: (02)2703-6070
財團法人預防醫學基金會
updated : 25 Feb, 2025